SCHEMBL2070191

SCHEMBL2070191

CCOC(=O)c1coc(CS(=O)(=O)c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
CDK5 Q00535 2/20 0.45
CDK5R1 Q15078 2/20 0.45
CYP2C9 P11712 1/20 0.45
MAPT P10636 2/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
NPC1 O15118 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 1/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41
HSD11B1 P28845 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6422360 0.83 TSHR (0.43) ALDH1A1POLBCYP2C9MAPTNPC1
SCHEMBL11564835 0.79 CYP1A2 (0.50) ALDH1A1CYP1A2MAPTNPC1NPSR1
SCHEMBL9714181 0.76 CYP1A2 (0.51) ALDH1A1CYP1A2POLBKMT2AMEN1
SCHEMBL855444 0.75 CYP1A2 (0.50) ALDH1A1CYP1A2POLBKMT2AMEN1
SCHEMBL3385122 0.74 CYP1A2 (0.49) ALDH1A1CYP1A2POLBKMT2AMEN1
SCHEMBL2070116 0.74 CYP1A2 (0.49) ALDH1A1CYP1A2POLBKMT2AMEN1
SCHEMBL1707146 0.74 CYP1A2 (0.43) ALDH1A1CYP1A2POLBKMT2AMEN1
SCHEMBL2792417 0.73 ALDH1A1 (0.59) ALDH1A1CYP1A2KMT2AMAPTNPC1
SCHEMBL31434680 0.72 MAPT (0.44) ALDH1A1CYP1A2POLBCYP2C9MAPT
SCHEMBL740361 0.72 ADORA3 (0.49) ALDH1A1CYP1A2POLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906546-B2 Tetrahydrocarbazoles and derivatives HOFFMANN-LA ROCHE INC. (US) 2011-03-15 US disclosed
US-20100216833-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES DEHMLOW HENRIETTA 2010-08-26 US disclosed
EP-1732892-B1 TETRAHYDROCARBAZOLES AND DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-09-17 EP disclosed
EP-1732892-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-12-20 EP disclosed
WO-2005092856-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-10-06 WO disclosed
US-20050215577-A1 Tetrahydrocarbazoles and derivatives HOFFMANN-LA ROCHE INC. 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216833-A1 TETRAHYDROCARBAZOLES AND DERIVATIVES NR1H3, NR1H2, NR1H4 ALDH1A1 3812/4885CYP1A2 227/4885POLB 3543/4885
US-20050215577-A1 Tetrahydrocarbazoles and derivatives NR1H3, NR1H2, NR1H4 ALDH1A1 3812/4885CYP1A2 227/4885POLB 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.